A multi-institutional team of researchers, led by Georgia Tech's Francesca Storici, has discovered a previously unknown role ...

A multi-institutional team of researchers, led by Georgia Tech's Francesca Storici, has discovered a previously unknown role for RNA. Their insights ...

Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

This virus-based therapeutic vaccine encodes neoantigens (patient-specific mutations ... of indirectly or directly killing cancer cells. NEC’s neoantigen prediction system utilizes its proprietary AI, ...

Around five years ago, software developer Francisco Diaz-Mitoma discovered he had a hereditary cardiovascular condition that ...

Recursion struggles with losses and high cash burn despite a $500M IPO. See why RXRX stock remains a "Hold" amid funding ...

Guardant Health's heavy investment in R&D, growing from $10.9 million in 2016 to $365.1 million in 2023, indicates a focus on future growth. Learn more on GH stock here.

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

“Everything outside of mutations gives us a lot of hope in cancer research because these phenomena are ... Instead, they read the abstract, then examine the figures – the charts, graphs and other ...

BC Cancer, Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early ...

A new study led by Harvard Medical School researchers shed new light on how even a single defective copy of the ...